They are not intended to be used for drug or diagnostic purposes nor are they intended for human use
Inclusion criteria encompassed all studies employing in vitro models (e.g., fibroblast proliferation, keratinocyte migration, collagen synthesis assays), in vivo studies using animal models for wound healing assessments, clinical trials evaluating the efficacy and safety of tripeptides in human subjects, and studies utilizing molecular, biochemical, or histological analyses to determine the mechanisms of tripeptides in wound recovery
*After 68 weeks, participants administering once-weekly semaglutide treatment (combined with diet and exercise) experienced an average of 14.9% reduction in body weight, compared with 2.4% for the placebo
Efficient, respectful service
10.1080/15321819.2019.1692029 29 FuJ.HuangH.LiuJ.PiR.ChenJ.LiuP